Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,331 | 127,509 | 58,271 | 33,129 | 15,010 |
| Marketable Securities | 13,156 | N/A | N/A | N/A | 0 |
| Receivables | 111,514 | 94,245 | 98,478 | 45,949 | 36,290 |
| Inventories | 52,370 | 43,892 | 39,056 | 34,510 | 30,530 |
| Income taxes - deferred | N/A | N/A | N/A | 2,055 | N/A |
| Other current assets | 11,517 | 12,446 | 14,349 | 4,094 | 8,240 |
| TOTAL | $370,888 | $278,092 | $210,154 | $119,737 | $90,070 |
| Non-Current Assets | |||||
| PPE Net | 203,458 | 187,875 | 155,919 | 117,001 | 85,410 |
| Investments And Advances | 0 | 0 | 3,002 | 2,442 | 21,720 |
| Intangibles | 135,723 | 130,736 | 90,374 | 41,893 | 0 |
| Other Non-Current Assets | 89,485 | 104,641 | 111,913 | 132,472 | 165,830 |
| TOTAL | $428,666 | $423,252 | $361,208 | $293,808 | $272,960 |
| Total Assets | $799,554 | $701,344 | $571,362 | $413,545 | $363,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 319 | N/A | N/A | 231 | 3,290 |
| Accounts payable and accrued liabilities | 19,433 | 13,084 | 13,868 | 10,767 | 9,290 |
| Accrued Expenses | 56,094 | 60,182 | 54,635 | 44,635 | 46,520 |
| Other current liabilities | 7,659 | 6,038 | 3,771 | N/A | 7,640 |
| TOTAL | $114,351 | $113,369 | $98,532 | $64,320 | $69,730 |
| Non-Current Liabilities | |||||
| Long Term Debt | 185,683 | 192,484 | 155,506 | 201,957 | 381,700 |
| Deferred Revenues | 30,846 | 27,029 | 22,210 | 5,223 | N/A |
| aiOther Non-Current Liabilities | 34,897 | 26,920 | 16,070 | 16,745 | 15,960 |
| TOTAL | $220,580 | $230,599 | $183,320 | $229,361 | $403,440 |
| Total Liabilities | $334,931 | $343,968 | $281,852 | $293,681 | $473,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,075 | 44,742 | 44,234 | N/A | N/A |
| Common Shares | 458 | 452 | 442 | 359 | 100 |
| Retained earnings | -152,885 | -233,036 | -283,168 | -318,575 | -307,350 |
| Other shareholders' equity | 7,269 | -11,768 | -16,673 | -13,324 | -9,920 |
| TOTAL | $464,623 | $357,376 | $289,510 | $119,864 | $-110,140 |
| Total Liabilities And Equity | $799,554 | $701,344 | $571,362 | $413,545 | $363,050 |